According to a recent LinkedIn post from Strive Health, the company is promoting a virtual discussion focused on trends expected to redefine kidney care in 2026. The post underscores the scale of the U.S. kidney disease burden, citing 37 million Americans affected and emphasizing the need for earlier intervention, smarter care models, and equitable access.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The event, as described in the post, will feature clinical leaders who are involved in efforts to improve care and patient outcomes in kidney health. For investors, this emphasis on value-based care and innovation in chronic kidney disease management may signal Strive Health’s intention to position itself as a leading participant in outcomes-focused kidney care models, a segment that could benefit from continued payer and policy support.

